VETERINARY ONCOLOGY MARKET ANALYSIS INDUSTRY INSIGHTS, TRENDS, OUTLOOK, AND OPPORTUNITY ANALYSIS, 2020–2027
© Coherent market Insights. All Rights Reserved
REPORT DESCRIPTION Veterinary Oncology Market - Overview Global Veterinary Oncology Market, by Animal Type (Companion Animal (Equine, Canine, and Feline), and Livestock Animal), by Therapy Type (Chemotherapy, Combination Therapy, Immunotherapy, and Targeted Therapy), by Mode of Administration (Oral and Intravenous), by Application (Canine Lymphoma, Osteosarcoma (OSA), Mast Cell Cancer, Melanoma, and Multiple Myeloma), by Distribution Channel (Hospital Pharmacies, Government Agencies, and Retail Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) was valued at US$ 401.8 Mn in 2018, and is projected to exhibit a CAGR of 10.9% over the forecast period (2019 - 2026), as highlighted in a new report published by Coherent Market Insights. Players operating in the global veterinary oncology market are focused on development, licensing, and commercialization of innovative therapeutics for dogs, cats, and horses. For instance, in 2017, the U.S. Food and Drug Administration conditionally approved Tanovea-CA1 (rabacfosadine) for injection for a term of one year. The drug manufactured by VetDC, Inc. is the first animal drug intended for the treatment of canine lymphoma. Moreover, the patented formulation of doxorubicin and patented XR17 technology by Oasmia Pharmaceuticals AB, Doxosphos Vet is currently under development for the treatment of lymphoma in dogs. Browse Research Reports: https://www.coherentmarketinsights.com/marketinsight/veterinary-oncology-market-2995 Š Coherent market Insights. All Rights Reserved
REPORT DESCRIPTION In addition to this, veterinary pharmaceutical companies are focused on strategic collaborations to develop and commercialize cancer treatments for companion animals. For instance, in 2017, Karyopharm and Anivive Lifesciences entered into an exclusive global license agreement to research and develop and commercialize Verdinexor (KPT-335), a drug for the treatment of lymphoma, which is in phase 2b of clinical trials. Browse 47 Market Data Tables and 45 Figures spread through 225 Pages and in-depth TOC on "Veterinary Oncology Market, By Animal Type (Companion Animal (Equine, Canine, and Feline) and Livestock Animal) , By Therapy Type (Chemotherapy, Combination Therapy, Immunotherapy, and Targeted Therapy), By Mode of Administration (Oral and Intravenous), By Application (Canine Lymphoma, Osteosarcoma (OSA), Mast Cell Cancer, Melanoma, and Multiple Myeloma), By Distribution Channel (Hospital Pharmacies, Government Agencies, and Retail Pharmacies), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Global Forecast to 2026." Besides, increasing demand for immunotherapy for the treatment of cancer in animals is expected to boost the market growth. Several immunotherapies for animals have been approved by the U.S. FDA. For instance, in 2016, Lymphocyte T-Cell Immunomodulator manufactured by T-Cyte Therapeutics, Inc. received a conditional license from the U.S. Department of Agriculture (USDA) for cats with Feline leukemia virus (FeLV). Request a Sample copy of this reports: https://www.coherentmarketinsights.com/insight/request-sample/2995 Š Coherent market Insights. All Rights Reserved
REPORT DESCRIPTION Key Takeaways of the Veterinary Oncology Market: The global veterinary oncology market is expected to witness a CAGR of 10.9% during the forecast period (2019–2026), owing to increasing number of approvals from regulatory agencies for novel therapies Among animal type, the companion animal segment is expected to hold major revenue share in 2026, owing to increasing R&D activities and manufacturing facility based on veterinary oncology for companion animals. For instance, in April 2018, Zoetis, Inc. established its animal vaccine research and manufacturing facility in Suzhou, China, which is focused on development and production of quality vaccines for companion animals. Major players operating in the global veterinary oncology market include, Zoetis Inc., Elanco, AB Science, Boehringer Ingelheim International GmbH, Zenoaq, VetDC Inc., Morphogenesis, Inc., Karyopharm Therapeutics, Inc., Regeneus Ltd., AdvaVet, Inc., and Rhizen Pharmaceutical SA The conditional approval allows the drug manufacturer to legally sell Tanovea-CA1, before standard of effectiveness for full approval. Buy-Now this Research Report @ https://www.coherentmarketinsights.com/insight/buy-now/2995 Š Coherent market Insights. All Rights Reserved
ABOUT COHERENT MARKET INSIGHTS ABOUT US Coherent Market Insights is a global market intelligence and consulting organization focused on assisting its plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, with an office at the global financial capital in the U.S. Our client base includes players from across all business verticals in over 150 countries worldwide. We are uniquely positioned to help businesses around the globe deliver practical and lasting results through various recommendations about operational improvements, technologies, emerging market trends and new working methods. We offer both customized and syndicated market research reports that help our clients create visionary growth plans to provide traction to their business. We meticulously study emerging trends across various industries at both the global and regional levels to identify new opportunities for our clientele.
SERVICES INDUSTRY ANALYSIS
CUSTOMIZED RESEARCH
SYNDICATED RESEARCH
MARKET INTELLIGENCE SERVICES
CONSULT STUDIES
COUNTRY SPECIFIC STUDIES
Š Coherent market Insights. All Rights Reserved
ABOUT CMI SECTOR COVERAGE
BIOTECHNOLOGY
CLINICAL DIAGNOSTIC
HEALTHCARE IT
MEDICAL DEVICES
MEDICAL IMAGING
PHARMACEUTICAL
OUR CLIENTS
Global Leading Equipment and System Manufacturers Marketing Consultancies and the Advertising Industry Component Providers and System Integrators
Private and Government organization
Distributors, Retailors and Value Added Resellers
Outsourcing Companies
Healthcare IT Solutions Developers
Universities and Business Schools.
© Coherent market Insights. All Rights Reserved
KEY STATS
RESEARCH SOLUTIONS
100+
FEASIBILITY STUDIES
Insights Published Per Year
GLOBAL REPORTS
150+
Consulting Projects Till Date
COUNTRY ANALYSIS CONSULT PROJECTS
125+
Clients Worldwide Per Year
110+
SURVEY RESEARCH
EXCEL FORECAST DATABASE
CUSTOMIZED SOLUTIONS
COMPETITIVE ASSESSMENT TECHNOLOGY SNIPPETS
Analysts and Contract Consultants
Coherent Market Insights excels at offering unmatched actionable market intelligence across various industry verticals, including chemicals, healthcare, and food & beverages, to name a few. We implement holistic market research methodology in order to result in the best possible market research reports across various industries worldwide. Based on our unmatched expertise across various industries—no matter how large or small, how complex or unique—we help our clients achieve better outcomes with uniquely designed and highly customized solutions. Our coverage includes insights that help our clients ensure sustained growth in developed markets and also key inputs to help them tap into emerging markets and exploit the plethora of opportunities posed therein. © Coherent market Insights. All Rights Reserved
THANK YOU To know more about us, visit our website: www.coherentmarketinsights.com For sales queries or new topics email us on: sales@coherentmarketinsights.com For other queries contact: Mr. Shah (Manager - Business Development) Coherent Market Insights sales@coherentmarketinsights.com +1-206-701-6702
Š Coherent market Insights. All Rights Reserved